C CAMBRIDGE PHARMA AN SMC LTD. COMPANY Trademark

Trademark Overview

On Friday, May 15, 2020, a trademark application was filed for C CAMBRIDGE PHARMA AN SMC LTD. COMPANY with the United States Patent and Trademark Office. The USPTO has given the C CAMBRIDGE PHARMA AN SMC LTD. COMPANY trademark a serial number of 88918271. The federal status of this trademark filing is REGISTERED as of Tuesday, April 4, 2023. This trademark is owned by Cambridge Pharma Limited. The C CAMBRIDGE PHARMA AN SMC LTD. COMPANY trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of pharmaceutical and biopharmaceutical preparations; custom assembly of pharmaceutical products; treatment of materials in the manufacture of pharmaceutical and biopharmaceutical preparations, namely, sterile filling of syringes, auto-injectors and other medical instruments with pharmaceutical and biopharmaceutical preparations during manufacture excluding pharmaceutical research and development and drug discovery
c cambridge pharma an smc ltd. company

General Information

Serial Number88918271
Word MarkC CAMBRIDGE PHARMA AN SMC LTD. COMPANY
Filing DateFriday, May 15, 2020
Status700 - REGISTERED
Status DateTuesday, April 4, 2023
Registration Number7019369
Registration DateTuesday, April 4, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements

Goods and ServicesCustom manufacture of pharmaceutical and biopharmaceutical preparations; custom assembly of pharmaceutical products; treatment of materials in the manufacture of pharmaceutical and biopharmaceutical preparations, namely, sterile filling of syringes, auto-injectors and other medical instruments with pharmaceutical and biopharmaceutical preparations during manufacture excluding pharmaceutical research and development and drug discovery
Description of MarkThe mark consists of the word "CAMBRIDGE" in the color orange above the word "PHARMA" in the color grey that is above a line with the words "AN SMC LTD. COMPANY" below the line in the color grey next to a design of a stylized letter "C" in the color grey with a half circle design in the colors orange and white.
Pseudo MarkC CAMBRIDGE PHARMA AN SMC LTD COMPANY; C CAMBRIDGE PHARMACEUTICALS AN SMC LIMITED COMPANY
Indication of Colors claimedThe color(s) orange, grey, and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"CAMBRIDGE PHARMA" OR "LTD. COMPANY"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, May 29, 2020
Primary Code040
First Use Anywhere DateMonday, February 15, 2021
First Use In Commerce DateMonday, February 15, 2021

Trademark Owner History

Party NameCambridge Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCambridge CB12JH
GB
Party NameCambridge Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCambridge CB12JH
GB
Party NameCambridge Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCambridge CB58EP
GB

Trademark Events

Event DateEvent Description
Tuesday, April 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 4, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, February 25, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 24, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 16, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, January 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 8, 2022NON-FINAL ACTION E-MAILED
Thursday, September 8, 2022SU - NON-FINAL ACTION - WRITTEN
Friday, August 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 18, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, August 8, 2022USE AMENDMENT FILED
Thursday, August 18, 2022SOU EXTENSION 3 GRANTED
Monday, August 8, 2022SOU EXTENSION 3 FILED
Tuesday, August 16, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 8, 2022TEAS EXTENSION RECEIVED
Monday, August 8, 2022TEAS STATEMENT OF USE RECEIVED
Monday, March 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 7, 2022SOU EXTENSION 2 GRANTED
Monday, February 7, 2022SOU EXTENSION 2 FILED
Monday, February 7, 2022TEAS EXTENSION RECEIVED
Wednesday, August 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 9, 2021SOU EXTENSION 1 GRANTED
Monday, August 9, 2021SOU EXTENSION 1 FILED
Monday, August 9, 2021TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 7, 2020EXAMINER'S AMENDMENT ENTERED
Saturday, November 7, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, November 7, 2020EXAMINERS AMENDMENT E-MAILED
Saturday, November 7, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2020NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2020NON-FINAL ACTION WRITTEN
Tuesday, August 25, 2020ASSIGNED TO EXAMINER
Thursday, August 13, 2020ASSIGNED TO EXAMINER
Saturday, May 30, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 19, 2020NEW APPLICATION ENTERED

Related Keywords

company pharma cambridge pharmaceutical biopharmaceutical preparations manufacture custom during medical excluding instruments drug